Your Health, We Care

Home >Drug List>Tivozanib>Indications of Tivozanib

Tivozanib(Fotivda)

Release date: 2026-01-05 15:40:45     Recommended: 102

Recurrent or refractory advanced renal cell carcinoma (RCC) after two or more previous systemic treatments.